Literature DB >> 26294949

Necrotizing Fasciitis of the Abdominal Wall Caused by Serratia Marcescens.

Naheed A Lakhani1, Umesh Narsinghani2, Ritu Kumar3.   

Abstract

In this article, we present the first case of necrotizing fasciitis affecting the abdominal wall caused by Serratia marcescens and share results of a focused review of S. marcescens induced necrotizing fasciitis. Our patient underwent aorto-femoral bypass grafting for advanced peripheral vascular disease and presented 3 weeks postoperatively with pain, erythema and discharge from the incision site in the left lower abdominal wall and underwent multiple debridement of the affected area. Pathology of debrided tissue indicated extensive necrosis involving the adipose tissue, fascia and skeletal muscle. Wound cultures were positive for Serratia marcescens. She was successfully treated with antibiotics and multiple surgical debridements. Since necrotizing fasciitis is a medical and surgical emergency, it is critical to examine infectivity trends, clinical characteristics in its causative spectrum. Using PubMed we found 17 published cases of necrotizing fasciitis caused by Serratia marcescens, and then analyzed patterns among those cases. Serratia marcescens is prominent in the community and hospital settings, and information on infection presentations, risk factors, characteristics, treatment, course, and complications as provided through this study can help identify cases earlier and mitigate poor outcomes. Patients with positive blood cultures and those patients where surgical intervention was not provided or delayed had a higher mortality. Surgical intervention is a definite way to establish the diagnosis of necrotizing infection and differentiate it from other entities.

Entities:  

Keywords:  S. Marcescens; community acquired infection; healthcare associated infection; necrotizing fasciitis; surgical intervention.

Year:  2015        PMID: 26294949      PMCID: PMC4508534          DOI: 10.4081/idr.2015.5774

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


Introduction

Necrotizing fasciitis, also known as flesh-eating disease, is a rare infection of the deeper layers of skin and subcutaneous tissues, and easily spreads across the fascial plane within those tissues. As bacterial toxins and the immune response cause vasoconstriction of the vasculature, the fascial spaces become avascular resulting in necrosis, which also prevents penetration of antibiotics into the tissues. Common causes are Group A streptococcus (GAS) (Streptococcus pyogenes), Staphylococcus aureus, Vibrio vulnificus, Clostridium perfringens, and Bacteroides fragilis. Mortality ranges from 4.2 to 38% with improving prognosis as time to treatment decreases. Serratia marcescens, a motile bacillus, gramnegative, facultative anaerobe, is an opportunistic pathogen of increasing importance. It is part of normal colon flora, and is also found in soil, sewage, and water. This Enterobacteriaceae organism also typically colonizes the respiratory and urinary tracts and causes infections in those organ systems. S. marcescens is often an opportunistic infection and may cause osteomyelitis, septic arthritis, endocarditis, and, rarely cellulitis or necrotizing fasciitis.[4-6] Soft tissue infections due to gram-negative organisms are relatively uncommon, and typical predisposing factors include: a history of trauma, alcoholism, peripheral vascular disease, systemic lupus erythematosus, immunosuppression, diabetes mellitus, urinary tract infection (UTI), bacteremia, pneumonia, infective arthritis, burns, and renal failure.[4,7] Other predisposing factors include: antibiotic use (most often first generation cephalosporins), steroid use, surgical instrumentation, urinary catheters, respiratory equipment, intravenous lines, injections, lacerations, abscesses, or ulcers. Common presentations of necrotizing fasciitis within 48 hours of infection include skin erythema and swelling at the affected site (97.6%), pyrexia (61.9%), hypotension (33.3%), altered consciousness (28.6%), bullous lesions (26.2%), and crepitus (9.5%). Hypotension, altered consciousness, ventilator support, ALT > two-fold of normal, serum creatinine >177 µmol/L, thrombocytopenia (<100×109/L), and worsening symptoms within 48 hours of admission have been associated with higher fatality rates. Lack of response to narrow-spectrum antibiotics, bullae formation, or a rapidly worsening clinical course, should heighten the suspicion for uncommon organisms like S. marcescens. Reports of S. marcescens necrotizing fasciitis cases have increased in the literature. In this study, we identify characteristics, trends, and risk factors of those infections to better prepare the medical community and prevent poor outcomes.

Materials and Methods

PubMed was used to search for cases of necrotizing fasciitis caused by Serratia marcescens published in the English language literature between 1966 and 2013. Keywords that were used included: Serratia marcescens, necrotizing, and fasciitis. We identified eleven additional cases of necrotizing fasciitis due to S. marcescens in the literature since the latest review in 2001, which are included in Table 1.[4,7,10-22] Cases were categorized as being healthcare-associated infections or community-acquired infections based on the Centers for Disease Control and Prevention (CDC) definition of healthcare-associated infections (HAIs) as infections that patients acquire during the course of receiving healthcare treatment for other conditions.
Table 1.

Serratia marcescens necrotizing fasciitis cases, 1966 to present.

AuthorYearAgeSexRisk factorsPrecipitating factorSite of infectionTypeS. marcescens culturesTreatmentOutcome
Rimailho et al.10198774MImmunocompromizedDilofenac consumptionLegCABlister and bloodNoneDied
Bornstein et al.11199237FRenal failure on hemodialysisPain during dialysisAxilla and chest wallHAWound, bullae, bloodAntibiotics and SDRecovered
Zipper et al.12199655FDiabetesLeft below-knee amputationLegCAWoundAntibioticsRecovered
Huang et al.13199973MNephrotic syndromeSteroid therapyLower legHANecrotic tissue, bloodAntibiotics and SDRecovered
Huang et al.13199940MUremia, peritoneal dialysis, SLEPneumonia with + cultures for S. marcescens, steroid and nabumetoneLeft calf and thighCANecrotic tissue, bloodAntibiotics and SDRecovered
Liangpunsakul et al.14200166FHealthyNoneLegCABloodAntibioticsDied
Newton et al.1520022FHealthyPharyngitisCervical spineCAWound, bloodAntibiotics and SDDied
Bachmeyer et al.16200449MSmall cell lung cancer, DMChemotherapy and cellulitisRight legHATissue, bullae, bloodAntibioticsRecovered
Curtis et al.4200551MESRD, T2DM, CHFScraped knee on rock in riverLeft legCAWound, bloodAntibiotics and SDDied
Statham et al.1720096MImmunocompetentSuspected pharyngitisOro-pharynxCAWound, bloodAntibiotics and SDRecovered
Motsitsi et al.18201137MHealthyHuman biteForearmCAWoundSDDied
Vano-Galvan et al.7201257F CML, immunocompromized Minor traumaRight thighHABlister, bloodAntibioticsDied
Prelog et al.19201215FAcute lymphocyctic leukemiaVenous access port implantationLeft axilla, venous HA access port siteWoundAntibiotics and SDRecovered
Wen et al.20201240FNephrotic syndrome, cyclosporine useChemotherapy 10 dayspriorLeft legCAWound, bloodAntibioticsDied
Rehman et al.21201254FSLE, end-stage renal diseaseCentral venous catheter, AV fistula ligation, steroid therapyChest wallHAWound, bloodAntibiotics and SDDied
Present case51FDM, PVDBifemoral bypass and left distal femoral aneurysm repairLower abdomenCAWound, bloodAntibiotics and SDRecovered
Cope et al.22201397FHeat failure, CKDHeart failure exacerbationRight legHAWound (post-mortem)AntibioticsDied

SD, Surgical debridement; CA, community-acquired infection; HA, healthcare-associated infection; SLE, systemic lupus erythematosus; ESRD, end-stage renal disease; T2DM, Type II, diabetes mellitus; PVD, peripheral vascular disease.

Case Report

We recently identified a case involving a 51-year-old African-American woman who presented 3 weeks postoperatively after undergoing a bifemoral bypass and left distal femoral aneurysm repair for symptomatic peripheral vascular disease. She had a long standing history of smoking and hypertension. On presentation, the patient reported having fever, chills, nausea, vomiting, and diarrhea for 6 days, redness and odorous discharge from her surgical incision site for one day. Additional history revealed that she was cleaning her wound with well water. On examination, there was erythema extending from the periumbilical area to her left groin, along with severe tenderness to palpation in that area. No crepitus was felt on palpation. Her temperature on admission was 36.9°C, blood pressure was 162/109 mmHg, respirations were 24 breaths per minute, and she was in no acute distress. Her white blood cell count was 9.8×109/L, C reactive protein (CRP) was 16.57 nmol/L, serum creatine kinase level was 57 U/L, serum electrolytes, renal, liver functions and immunoglobulin levels were normal and blood and urine cultures were negative. The patient was started on intravenous vancomycin and meropenem and underwent multiple debridements of the abdominal wound and left groin region. Intraoperative findings confirmed the presence of deep necrotic fascia and non-adherent subcutaneous tissue. Histopathology of debrided tissue indicated acute and chronic inflammation with infiltration of granulocytes and necrosis involving the fibroadipose tissue and skeletal muscle. Intraoperative wound cultures were positive for Serratia marcescens. Based on sensitivities, antibiotics were changed to intravenous levofloxacin MIC <2 mcg/mL. She also received negative-pressure wound therapy using vacuum assisted closure. The patient improved clinically and was successfully discharged on oral levofloxacin to complete a total of 3 weeks of treatment.

Results

Since 1966, there have been 17 documented cases of necrotizing fasciitis caused by S. marcescens (Table 1).[4,7,10-22] Eight (47%) of those cases occurred within the past five years.[4,7,15-24] Among all of the identified cases, 10 (59%) impacted a leg, and 1 (5.9%) affected the forearm, the cervical spine, the axilla and chest wall, a venous access site, the oropharynx, the chest wall, or the lower abdomen. Thirteen (77%) of the cases had blood cultures that were positive for S. marcescens. Ten cases (59%) were community-acquired infections, and 7 cases (41%) were healthcare-associated infections. An overwhelming number of cases (81.3%) had pre-existing open wounds. Seven cases (41%) were immunocompromized, 5 cases (29%) had kidney disease, and 4 cases (24%) had diabetes. A majority (59%) of the cases were among females. Three of the cases (18%) were children. Nine out of seventeen cases (53%) died as a result of necrotizing fasciitis and its complications. Six of the cases (67%) that died had community-acquired infections. Individuals with positive versus negative blood cultures were more likely to die (88% vs. 75%). Patients who did not receive surgical debridement had inferior outcomes; they had a mortality of 71% compared to 40% among those who received surgical intervention as opposed to debridement. Additionally, all patients (18%, n=3) who received only antibiotics and the one patient who received only surgical debridement died. All previously healthy patients (18%, n=3) also died. A majority of those that recovered had a surgical procedure in the hospital prior to symptom onset such as below the knee amputation or venous access port implantation (75%, n=8).

Discussion and Conclusions

Necrotizing fasciitis is a deep infection of the subcutaneous tissue that results in progressive destruction of fascia and fat. The disease is classified as type I (polymicrobial infection), type II (monomicrobial) and type III gas gangrene, or clostridial myonecrosis. Type I infection involves anaerobic species in combination with one or more facultative anaerobic streptococci (other than group A) and members of the Enterobacteriaceae family. Type II infection is commonly caused by group A streptococci or other beta-hemolytic streptococci that are isolated alone or in combination with other species, most frequently S. aureus. These infections are also commonly referred as flesh eating infection. Among those with necrotizing fasciitis, the affected area is typically erythematous, swollen, warm, and exquisitely tender. The infection progresses rapidly over several days, with changes in skin color from red-purple to patches of blue-gray. Skin breakdown with bullae (containing thick pink or purple fluid) and frank cutaneous gangrene may be observed within three to five days. The development of anesthesia may precede the appearance of skin necrosis and provide a clue that the process is necrotizing fasciitis rather than cellulitis. In advanced infection, high fever and systemic toxicity are generally observed. Individuals with positive blood cultures typically have poorer prognosis and higher mortality rates.[1,25] Treatment of necrotizing infection consists of early and aggressive surgical exploration and debridement of necrotic tissue, together with broad spectrum empiric antibiotic therapy and hemodynamic support as necessary.[4,26] Acceptable antibiotic regimens prior to identification of the causative organism(s) include administration of a carbapenem or beta-lactam/beta-lactamase inhibitor, together with clindamycin (600 to 900 milligrams intravenously every eight hours), as well as an agent with activity against MRSA. Definitive antibiotic treatment should be tailored according to blood and or tissue gram stain, culture, and sensitivity results when available. If S. marcescens is identified as the main pathogen, third-generation cephalosporins, fluoroquinolones, and imipenem/cilastatin are the antimicrobials of choice. Our patient’s fever on presentation was likely masked by the pain medications she was taking, though she did give a history of having fever at home. She most likely had a subacute course and thus lacked the classic features of rapid clinical progression and fulminant toxicity. An HIV test was not performed, as the patient did not have any risk factors or any previous sexually transmitted disease. Our review noted a mortality rate of 53% among those with S. marcescens-induced necrotizing fasciitis, which is higher than the mortality rate reported by Elliott et al. in 1996 and nearly equivalent (53% vs. 50%) to the mortality rate documented by Nancy et al. in 2002. Patients who died were more likely to have positive blood cultures, present with a community-acquired illness, be previously healthy, experience minor trauma or sickness prior to symptom onset, and not receive both surgical debridement and antibiotic therapy. Similar observations of increased mortality among those with positive blood cultures or those not receiving appropriate antibiotic and surgical treatment were also found in other studies.[4,26] Increased mortality among individuals with less severe injury, lack of traditional risk factors, and those who did not have a recent surgical procedure in the hospital may have been due to less vigilance about changes in health status and the fact that S. marcescens is common in the outdoor environment; these individuals were also more likely to have community-acquired infections (70% vs. 30%). Additionally, individuals who had been hospitalized recently were more likely to have received antibiotics in the near past and also more likely to be wary of any new symptoms. Healthy patients also tend to seek care later and receive less aggressive treatment; only one of the previously healthy patients received both antibiotics and surgical debridement. Clinicians should be wary of necrotizing fasciitis among those with soft tissue infections presenting after environmental open skin exposure. Gram-negative bacilli, including S. marcescens, should especially be considered in cases of necrotizing fasciitis or cellulitis among immunocompromized persons with renal failure, steroid use, recent surgery or diabetes. Early diagnosis is key, but unfortunately is missed in 85 to 100% of cases since necrotizing fasciitis is often confused with cellulitis, myositis, or deep-seated abscess(es). A high index of suspicion is important in view of the paucity of specific cutaneous findings early in the course of the disease. Radiographic imaging studies may be useful in determining if muscle tissue is involved but should not delay surgical intervention. Our case also underscores the importance of preoperative and more so, postoperative wound care education, which could have potentially prevented this fatal complication. The most effective treatment regimen for suspected necrotizing fasciitis includes: early and aggressive surgical exploration and debridement, immediate broad spectrum empiric antibiotic therapy, and hemodynamic support as necessary.[4,26]
  26 in total

1.  Necrotizing fasciitis caused by Serratia marcescens: a fatal complication of nephrotic syndrome.

Authors:  Yao-Ko Wen
Journal:  Ren Fail       Date:  2012-03-08       Impact factor: 2.606

2.  Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host.

Authors:  Sergio Vano-Galvan; Iván Álvarez-Twose; Paula Moreno-Martín; Pedro Jaén
Journal:  Int J Dermatol       Date:  2012-05-29       Impact factor: 2.736

3.  Necrotizing fasciitis caused by Serratia marcescens in two patients receiving corticosteroid therapy.

Authors:  J W Huang; C T Fang; K Y Hung; P R Hsueh; S C Chang; T J Tsai
Journal:  J Formos Med Assoc       Date:  1999-12       Impact factor: 3.282

4.  Fatal necrotizing fasciitis following human bite of the forearm.

Authors:  N S Motsitsi
Journal:  J Hand Surg Eur Vol       Date:  2011-07-01

Review 5.  Serratia marcescens: historical perspective and clinical review.

Authors:  V L Yu
Journal:  N Engl J Med       Date:  1979-04-19       Impact factor: 91.245

Review 6.  Serratia marcescens infections.

Authors:  J F Acar
Journal:  Infect Control       Date:  1986-05

Review 7.  Necrotizing fasciitis: classification, diagnosis, and management.

Authors:  Luca Lancerotto; Ilaria Tocco; Roberto Salmaso; Vincenzo Vindigni; Franco Bassetto
Journal:  J Trauma Acute Care Surg       Date:  2012-03       Impact factor: 3.313

8.  Serratia marcescens causing cervical necrotizing oropharyngitis.

Authors:  Melissa M Statham; Amit Vohra; Deepak K Mehta; Troy Baker; Robert Sarlay; Michael J Rutter
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-12-10       Impact factor: 1.675

9.  Serratia marcescens necrotizing fasciitis presenting as bilateral breast necrosis.

Authors:  Tayyab Rehman; Thomas A Moore; Leonardo Seoane
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

10.  The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis.

Authors:  I-Chuan Chen; Wen-Cheng Li; Yu-Cheng Hong; Shian-Sen Shie; Wen-Chih Fann; Cheng-Ting Hsiao
Journal:  Crit Care       Date:  2011-06-21       Impact factor: 9.097

View more
  6 in total

1.  A Case of Subacute Necrotizing Fasciitis due to Serratia marcescens.

Authors:  Michael Roberts; David Crasto; David Roy
Journal:  J Clin Aesthet Dermatol       Date:  2021-01-01

Review 2.  Necrotizing fasciitis due to Serratia marcescens: case report and review of the literature.

Authors:  Rohit Majumdar; Nancy F Crum-Cianflone
Journal:  Infection       Date:  2015-10-23       Impact factor: 3.553

3.  Sudden death of an Indian peafowl (Pavo cristatus) at a zoo due to non-pigmented Serratia marcescens infection.

Authors:  Seung-Hun Lee; Sang-Joon Park; Dongmi Kwak; Kyoo-Tae Kim
Journal:  J Vet Med Sci       Date:  2017-10-30       Impact factor: 1.267

4.  Severe and Progressive Cellulitis Caused by Serratia marcescens Following a Dog Scratch.

Authors:  Deeti J Pithadia; Erena N Weathers; Rhonda E Colombo; Stephanie L Baer
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

5.  Draft Genome Sequence of Serratia marcescens Strain ZZCCN01, Isolated from the Cardiac Blood of a Beef Cow.

Authors:  Yu-Long Zhang; Fang-Yuan Huang; Cai-Xia Yao; Dong-Jie Cai; Zhi-Sheng Wang; Zhi-Cai Zuo
Journal:  Microbiol Resour Announc       Date:  2020-12-03

6.  An unusual location of squamous cell carcinoma and a rare cutaneous infection caused by serratia marcescens on the tumoral tissue: A case report.

Authors:  Nurhayat Ozkan Sevencan; Elcin Kal Cakmakliogullari; Aysegul Ertinmaz Ozkan; Burcak Kayhan
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.